Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Authors
Keywords
-
Journal
CLINICAL DRUG INVESTIGATION
Volume 40, Issue 8, Pages 695-713
Publisher
Springer Science and Business Media LLC
Online
2020-06-24
DOI
10.1007/s40261-020-00942-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging role of GIP and related gut hormones in fertility and PCOS
- (2020) R. Charlotte Moffett et al. PEPTIDES
- Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial
- (2020) Dimitris Papamargaritis et al. BMJ Open
- The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controls
- (2019) H Kahal et al. GYNECOLOGICAL ENDOCRINOLOGY
- GLP-1 receptor agonists versus metformin in polycystic ovary syndrome: a systematic review and meta-analysis
- (2019) Yi Han et al. REPRODUCTIVE BIOMEDICINE ONLINE
- The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective
- (2019) Mojca Jensterle et al. HUMAN REPRODUCTION UPDATE
- An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity
- (2019) Simona Ferjan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension
- (2019) Subhi Talal Younes et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
- (2019) Liying Zhu et al. BIOMEDICINE & PHARMACOTHERAPY
- Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study
- (2018) Vesna Salamun et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡
- (2018) Helena J Teede et al. HUMAN REPRODUCTION
- Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells
- (2018) Yuki Nishiyama et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
- (2018) Héctor F. Escobar-Morreale Nature Reviews Endocrinology
- The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications
- (2018) Daniel J. Drucker DIABETES
- Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis
- (2018) F.-F. Wang et al. Obesity Reviews
- Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study
- (2017) Simona Ferjan et al. Metabolic Syndrome and Related Disorders
- Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial
- (2017) Malin Nylander et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
- (2017) Mojca Jensterle et al. BMC Endocrine Disorders
- GLP-1 receptor agonists in the treatment of polycystic ovary syndrome
- (2017) Elizabeth Mary Lamos et al. Expert Review of Clinical Pharmacology
- Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
- (2017) Malin Nylander et al. Endocrine Connections
- Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
- (2016) Preman Kumarathurai et al. DIABETES CARE
- The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
- (2016) Robert L. Rosenfield et al. ENDOCRINE REVIEWS
- Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study
- (2016) Signe Frøssing et al. GYNECOLOGICAL ENDOCRINOLOGY
- Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
- (2016) MOJCA JENSTERLE et al. Experimental and Therapeutic Medicine
- Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters
- (2016) U. Durmus et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries
- (2015) Mitra Niafar et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- State of the art paper Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns
- (2015) Georgios S. Papaetis et al. Archives of Medical Science
- Normal pregnancy outcome after first-trimester exposure to liraglutide in a woman with Type 2 diabetes
- (2015) D. Greco DIABETIC MEDICINE
- Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
- (2015) Daniel A. Dumesic et al. ENDOCRINE REVIEWS
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study
- (2015) Mojca Jensterle et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Targets to treat metabolic syndrome in polycystic ovary syndrome
- (2015) Shruthi Mahalingaiah et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study
- (2015) Tzuchun Lin et al. HUMAN REPRODUCTION
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
- (2015) Richard S. Legro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
- (2015) Agathe Dumont et al. Reproductive Biology and Endocrinology
- The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
- (2015) Hassan Kahal et al. BMC Endocrine Disorders
- Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
- (2015) Mojca Jensterle et al. Journal of Ovarian Research
- Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome
- (2015) Vanessa Hoang et al. PLoS One
- Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome
- (2014) Kadriye Aydin et al. CLINICAL ENDOCRINOLOGY
- Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity
- (2014) Samantha Cassar et al. CLINICAL ENDOCRINOLOGY
- Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome
- (2014) Mojca Jensterle et al. ENDOCRINE RESEARCH
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- (2014) Gerard Conway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials
- (2014) Stefano Palomba et al. Reproductive Biology and Endocrinology
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- (2014) Evangeline Vassilatou WORLD JOURNAL OF GASTROENTEROLOGY
- The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
- (2014) Christina B. Rasmussen et al. Frontiers in Endocrinology
- Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
- (2013) H. Kahal et al. CLINICAL ENDOCRINOLOGY
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- (2013) Mojca Jensterle Sever et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Increased protein expression of LHCG receptor and 17 -hydroxylase/17-20-lyase in human polycystic ovaries
- (2013) F. V. Comim et al. HUMAN REPRODUCTION
- Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
- (2012) Evanthia Diamanti-Kandarakis et al. ENDOCRINE REVIEWS
- Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
- (2012) S.S. Lim et al. HUMAN REPRODUCTION UPDATE
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Obesity and PCOS: Implications for Diagnosis and Treatment
- (2012) Richard Legro SEMINARS IN REPRODUCTIVE MEDICINE
- Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
- (2011) Georgios S. Papaetis et al. CURRENT DRUG TARGETS
- The Incretin Effect and Secretion in Obese and Lean Women with Polycystic Ovary Syndrome: A Pilot Study
- (2011) Charalambos Pontikis et al. JOURNAL OF WOMENS HEALTH
- Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells
- (2010) Joan M. McKiney et al. BIOLOGICAL CHEMISTRY
- Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice
- (2010) A. Maida et al. DIABETOLOGIA
- Liraglutide: the therapeutic promise from animal models
- (2010) L. B. Knudsen INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- (2009) Stefano Palomba et al. ENDOCRINE REVIEWS
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- (2009) Evanthia Diamanti-Kandarakis et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin
- (2009) Pernille Fog Svendsen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Incretin levels in polycystic ovary syndrome
- (2008) Jana Vrbikova et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Follicle dynamics and anovulation in polycystic ovary syndrome
- (2008) S. Franks et al. HUMAN REPRODUCTION UPDATE
- Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance
- (2008) Theodore P. Ciaraldi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
- (2008) D RUSSELLJONES MOLECULAR AND CELLULAR ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started